Man Group plc - CYTOMX THERAPEUTICS INC ownership

CYTOMX THERAPEUTICS INC's ticker is CTMX and the CUSIP is 23284F105. A total of 128 filers reported holding CYTOMX THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is 2.74 and the average weighting 0.0%.

Quarter-by-quarter ownership
Man Group plc ownership history of CYTOMX THERAPEUTICS INC
ValueSharesWeighting
Q1 2023$75,953
+37.3%
50,300
+45.5%
0.00%
Q4 2022$55,320
+53.7%
34,575
+36.0%
0.00%
Q3 2022$36,000
-47.1%
25,430
-32.2%
0.00%
Q2 2022$68,000
-80.8%
37,501
-18.5%
0.00%
-100.0%
Q1 2021$355,000
-79.7%
45,988
-82.8%
0.00%
-75.0%
Q4 2020$1,749,000
+18.6%
266,986
+20.4%
0.01%
+33.3%
Q3 2020$1,475,000
-8.9%
221,812
+14.1%
0.01%
-25.0%
Q2 2020$1,619,000
-22.5%
194,412
-28.6%
0.01%
-42.9%
Q1 2020$2,089,000
-21.6%
272,410
-15.0%
0.01%
+55.6%
Q4 2019$2,665,000
+3406.6%
320,655
+2999.3%
0.01%
Q3 2019$76,000
-91.4%
10,346
-87.4%
0.00%
-100.0%
Q1 2019$879,000
-57.6%
81,798
-40.4%
0.00%
-66.7%
Q4 2018$2,073,000
-36.4%
137,261
-22.1%
0.01%
-25.0%
Q3 2018$3,259,000
-60.6%
176,160
-51.3%
0.01%
-64.7%
Q2 2018$8,270,000
-28.7%
361,750
-11.2%
0.03%
-35.8%
Q1 2018$11,593,000407,4830.05%
Other shareholders
CYTOMX THERAPEUTICS INC shareholders Q1 2021
NameSharesValueWeighting ↓
GREAT POINT PARTNERS LLC 1,500,000$7,635,0001.78%
Altium Capital Management LP 1,233,642$6,279,0001.65%
RA Capital Management 3,500,000$17,815,0000.25%
Soleus Capital Management, L.P. 261,050$1,329,0000.21%
Affinity Asset Advisors, LLC 125,000$636,0000.16%
PLATINUM INVESTMENT MANAGEMENT LTD 1,078,103$5,488,0000.16%
Point72 Asset Management, L.P. 6,303,025$32,082,0000.14%
GSA CAPITAL PARTNERS LLP 249,146$1,268,0000.13%
Candriam S.C.A. 3,305,940$16,826,0000.11%
RTW INVESTMENTS, LP 1,400,939$7,131,0000.11%
View complete list of CYTOMX THERAPEUTICS INC shareholders